TFBS Bioscience Inc. (TPEX:6939)
Taiwan · Delayed Price · Currency is TWD 17.60
-0.55 (-3.03%)
Nov 6, 2026, 1:39 PM CST
TFBS Bioscience Market Cap
TFBS Bioscience has a market cap or net worth of 614.93 million as of November 6, 2026. It is the 37,199th most valuable company in the world and the 2,215th biggest in Taiwan. Its market cap has decreased by 25.11% in one year.
Market Cap
614.93M
Enterprise Value
n/a
Revenue
n/a
Global Rank
Country Rank
#2,215 Taiwan
PE Ratio
n/a
ChartMarket Cap Chart
Since May 15, 2023, TFBS Bioscience's market cap has decreased from 2.35B to 614.93M, a decrease of -73.82%. That is a compound annual growth rate of -31.94%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 6, 2026 | 634.15M | -15.19% |
| Dec 31, 2025 | 747.70M | -24.34% |
| Dec 31, 2024 | 988.18M | -39.96% |
| Dec 29, 2023 | 1.65B | -29.93% |
| May 15, 2023 | 2.35B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| BIONET | 2.38B |
| DIVA Laboratories | 1.84B |
| Puriblood Medical | 1.01B |
| Genetics Generation Advancement | 991.69M |
| Kim Forest Enterprise | 772.92M |
| Sofiva Genomics | 711.50M |
| Pharmigene | 416.84M |
| Welgene Biotech | 362.38M |